Rifampicin

Specifications

13292-46-1CAS Number

236-312-0EC Number

[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-oIUPAC Name

C43H58N4O12Chemical Formula

822.9 g/molMolecular Weight

Rifampicin; rifampin; 13292-46-1; Rifaldazine; Rifamycin AMP; Rifaprodin; Rifoldin; Rifa; Rifampicinum; Riforal; Abrifam; Eremfat; L-5103 Lepetit; Rifaldin; Rifoldine; R/AMP; Rifampicina; Rifampicine; Ba 41166/E; Rifapiam; BA-41166E; NSC-113926; 3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; DTXSID6021244; VJT6J7R4TR; NSC113926; L-5103-LEPETIT; L-5103; [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate; NIH-10782; 8-(4-Methylpiperazinyliminomethyl) rifamycin SV; BA-41166/E; 8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV; Rifomycin SV, 8-(N-(4-methyl-1-piperazinyl)formidoyl)-; CHEBI:28077; 2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-, 21-acetate; Rifampin (Rifampicin); (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1(4,7).0(5,28)]triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate; DTXCID301244; 3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV; 8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv; Rifomycin sv, 8-[N-(4-Methyl-1-piperazinyl)formidoyl]-; Rifadin Iv; ((7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-((E)-(4-methylpiperazin-1-yl)iminomethyl)-6,23-dioxo-8,30-dioxa-24-azatetracyclo(23.3.1.14,7.05,28)triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl) acetate; (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-((E)-((4-methylpiperazin-1-yl)imino)methyl)-6,23-dioxo-8,30-dioxa-24-azatetracyclo(23.3.1.1(4,7).0(5,28))triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate; Rifadin IV NOVAPLUS; RefChem:55979; J04AB02; (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-Pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(4-methylpiperazin-1-yliminomethyl)-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-21-yl acetate; (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-13-acetyloxy-15,17,27,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-((E)-(4-methylpiperazin-4-ium-1-yl)iminomethyl)-6,23-dioxo-8,30-dioxa-24-azatetracyclo(23.3.1.14,7.05,28)triaconta-1(29),2,4,9,19,21,25,27-octaen-2-olate; (7S,9Z,11S,12R,13S,14R,15R,16R,17S,18S,21Z)-2,15,17,23,27,29-hexahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-(((4-methylpiperazin-1-yl)imino)methyl)-6-oxo-8,30-dioxa-24-azatetracyclo(23.3.1.14,7.05,28)triaconta-1(28),2,4,9,19,21,23,25(29),26-nonaen-13-yl acetate; 236-312-0; Rifadin; Rimactane; Rimactan; Tubocin; Archidyn; Rifadine; Rimactizid; Rifagen; Rimazid; Rifampicin SV; Arficin; Benemicin; Doloresum; Fenampicin; Rifaldazin; Rifamor; Rifobac; Sinerdol; Arzide; Rifcin; Rifam; Dione 21-acetate; Rifinah; Rimactazid; Rifampicine [French]; Rifampicinum [INN-Latin]; Rifampicina [INN-Spanish]; CCRIS 551; Rifadin I.V.; HSDB 3181; Rifamycin, 3-(((4-methyl-1-piperazinyl)imino)methyl)-; RFP; 3-(4-Methylpiperazinyliminomethyl)-rifamycin SV; C43H58N4O12; Rifamycin, 3-[[(4-methyl-1-piperazinyl)imino]methyl]-; (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate; 5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione 21-acetate; Rifampin [USAN]; rifamcin; Rifamsolin; Rifampicin [INN:BAN:JAN]; Famcin; Rimactane;; Rifadin;; Rifampicin RS; Rifampicin CRS; Rimactane (TN); Rifampin (USP); (2S,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-Pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate; [pentahydroxy-methoxy-heptamethyl-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-dioxo-[?]yl] acetate; 5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione 21-acetate; Rifampicin & EEP; Prestwick_833; EINECS 236-312-0; R-Cin; Rifadin (TN); NSC 113926; Piperine & Rifampicin; Rifampicin & Propolis; Rifampicin (Standard); 3-(4-Methylpiperazinyliminomethyl)rifamycin SV; Reserpine & Rifampicin; RIFAMPIN [HSDB]; Rifampin [USAN:USP]; RIFAMPIN [MI]; RIFAMPICIN [INN]; RIFAMPICIN [JAN]; RIFAMPIN [VANDF]; 8-(n-(4-methyl-1-piperazinyl)formidoyl)-rifomycins; Prestwick2_000525; Prestwick3_000525; Spectrum5_002018; UNII-VJT6J7R4TR; RIFAMPICIN [IARC]; 3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin; 3-[[(4-Methyl-1-piperazinyl)imino]methyl]-rifamycin; Rifampicin (JP18/INN); RIFAMPICIN [MART.]; RIFAMYCIN AMP [MI]; 3-(((4-METHYL-1-PIPERAZINYL)IMINO)METHYL)RIFAMYCIN; RIFAMPICIN [WHO-DD]; RIFAMPICIN [WHO-IP]; SCHEMBL23490; BSPBio_000509; RIFAMPIN [ORANGE BOOK]; 8CI); BPBio1_000561; CHEMBL374478; GTPL2765; orb1226535; RIFAMPICIN [EP IMPURITY]; RIFAMPIN [USP MONOGRAPH]; SCHEMBL22517710; SCHEMBL29400640; HY-B0272R; RIFATER COMPONENT RIFAMPIN; RIFAMPICIN [EP MONOGRAPH]; RIFAMATE COMPONENT RIFAMPIN; HMS1569J11; HMS2089F12; HMS2096J11; HMS3713J11; DRG-0109; MSK10166; Rifampicin, >=97.0% (HPLC); RIFAMPICINUM [WHO-IP LATIN]; Rifampicin, powder, gamma-irradiated; Ba 41166; BDBM50370232; GR-306; AKOS015951372; Rifampicin, >=97% (HPLC), powder; AR11351; BA 411661E; CCG-208267; DB01045; NCGC00022678-03; NCGC00022678-04; NCGC00022678-05; NCGC00022678-06; NCGC00022678-09; 1,25(29),26-octaen-13-yl acetate; ST057531; NS00011698; R3220; C06688; D00211; Rifampicin, VETRANAL(TM), analytical standard; AB00383022_07; Q422652; SR-05000002118; 8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin; 8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv; SR-05000002118-3; WLN: V1 WQ A&1 E&1 E1UN- AT6N DNTJ D1; 3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV; Rifampicin, European Pharmacopoeia (EP) Reference Standard; Rifampin, United States Pharmacopeia (USP) Reference Standard; Rifampin, Pharmaceutical Secondary Standard; Certified Reference Material; yclo[23.3.1.1^{4,7}.0^{5,28}]triaconta-1(28),2,4,9,19,2; 4,7>.0<5,28>]triaconta-1(28),2,4,9,1 9,21,25(29),26-octaen-13-yl acetate; Rifampicin, plant cell culture tested, BioReagent, >=97% (HPLC), crystalline; yl]-, (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-; (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl ac; (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11- methoxy-3,7,12,14,16,18,22-heptamethyl-26-{(E)-[(4-methylpiperazin-1-yl)imino] methyl}-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1 (28),2,4,9,19,21,25(29),26-octaen-13-yl acetate; (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-N-(4-methylpiperazin-1-yl)carboximidoyl]-6,23-dioxo-8,30-dioxa-24-azatetrac; (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-Pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-{(E)-[(4-methyl-1-piperazinyl)imino]methyl}-6,23-dioxo-8,30-dioxa-24-azatetracyc; (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1(4,7).0(5,28)]triaconta-1(28),2,4,9,19,21,25(29),26-octaen-13-yl acetate; 2,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate; 2,7-(epoxy[1,11,13]pentadecatrienoimino)naphtho[2,1-b]furan-1,11(2H)-dione, 21-(acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[(E)-[(4-methyl-1-piperazinyl)imino]meth; 2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-, 21-acetate (; 26-[(1E)-2-(4-methylpiperazinyl)-2-azavinyl](7S,11S,13S,17S,18S,12R,14R,15R,16 R)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-d ioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1<; 5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-beta)furan-1,11(2H)-dione 21-acetate; 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate; Rifampicin in combination with actinonin, BB-3497, hydroxylamine hydrochloride, and 1,10-phenanthroline; Stereoisomer of 5,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-he@ptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione 21-acetateSynonyms